Conference abstract · 16 Aug 2018
EditorialPublished 20 Feb 2017
EGFR - An Evolving Cancer Target
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The Epidermal Growth Factor Receptor (EGFR) plays an important role in initiating the signaling that directs the behaviour of epithelial cells and tumors of epithelial origin. EGFR is involved in cell signaling that controls cell proliferation, survival, and metastasis by regulating diverse cellular pathways, and is the most frequently mutated receptor in lung cancer (10% in the USA, 35% in Asia) [1,2], prompting an intensive effort to develop an effective drug to overcome EGFR-mutant-driven cancers. Resistance to EGFR tyrosine kinase inhibitors occurs in many cases of lung cancer. Here, we present a concise overview of the mechanisms involved in resistance and discusses a new approach to overcoming them.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 16 Aug 2018
Immunoliposomes containing simvastatin, targeted towards EGFR, as potential therapeutic for a treatment of EGFR-dependent breast cancer tumors
Conference abstract · 28 Sep 2015
The EGFR-targeted chimeric antigen receptor-modified T cells immunotherapy for patients with EGFR-expressing advanced or relapsed/refractory solid tumors
Editorial · 2014
Current Molecularly Targeted Therapies against EGFR for Cancer
Conference abstract · 15 Aug 2011
Targeting EGFR for fluorescence optical imaging of cancer
More from this journal
The newest in Cancer Biology and Therapeutic Oncology.
Research article · 26 Jul 2022
Morphine Promotes Breast Cancer Cell Proliferation via andmu;-Opioid Receptor Independent-MRG Dependent Signaling: An in vitro Study
Review article · 28 Jun 2022
Meddling of Viral Genome can Contribute Cancer by Cumulating the Global Burden
Conference abstract · 27 Mar 2022
Research progress of YTH domain protein family
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Biology and Therapeutic Oncology
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Dakir EL-H”
- BylineArticles whose byline prints “Tanani EL-M”
- BylineArticles whose byline prints “Dakir NM”
- BylineArticles whose byline prints “Mendoza A”
- BylineArticles whose byline prints “Morgan R”

